Point Mutation in the Group B Streptococcal pbp2x Gene Conferring Decreased Susceptibility to β-Lactam Antibiotics
2008 ◽
Vol 52
(8)
◽
pp. 2915-2918
◽
Keyword(s):
ABSTRACT Beta-lactam antibiotics (BLAs) are the first-line agents used against group B streptococci (GBS) infection. A clonal set of four independent, invasive GBS isolates with elevated MICs to BLAs were identified that shared a pbp2x mutation (Q557E) corresponding to a resistance-conferring pneumococcal mutation. BLA sensitivity was restored through allelic replacement or complementation with the wild-type pbp2x.
2004 ◽
Vol 52
(Suppl 1)
◽
pp. S294.4-S294
Keyword(s):
1982 ◽
Vol 22
(5)
◽
pp. 897-900
◽
Keyword(s):
2020 ◽
Vol 7
(Supplement_1)
◽
pp. S173-S174
Keyword(s):
2019 ◽
Vol 18
(1)
◽
pp. 37-46
Keyword(s):